SCHEMBL3470841

SCHEMBL3470841

CC1(C)CC(Nc2nccc(-c3ccc(-c4cccc(CC=O)c4)s3)n2)CC(C)(C)N1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.37
AKT3 Q9Y243 2/20 0.35
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 1/20 0.34
ERN1 O75460 1/20 0.34
CCNA2 P20248 3/20 0.34
CDK2 P24941 3/20 0.34
MAPK3 P27361 2/20 0.34
MAPK1 P28482 2/20 0.34
KMT2A Q03164 1/20 0.34
ROCK2 O75116 4/20 0.34
AURKA O14965 1/20 0.33
TTK P33981 1/20 0.33
AURKB Q96GD4 1/20 0.33
INCENP Q9NQS7 1/20 0.33
MAPK14 Q16539 3/20 0.33
CDK1 P06493 1/20 0.32
CDK4 P11802 1/20 0.32
CCNB1 P14635 1/20 0.32
CCND1 P24385 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16192726 0.91 IKBKB (0.35) KCNH2AKT3KDM4ECCNA2CDK2
SCHEMBL3474930 0.89 KCNH2 (0.38) KCNH2AKT3KDM4EALDH1A1ROCK2
SCHEMBL3478518 0.89 KCNH2 (0.38) KCNH2AKT3KDM4EALDH1A1CCNA2
SCHEMBL27842565 0.84 KCNH2 (0.36) KCNH2CCNA2CDK2MAPK3MAPK1
SCHEMBL3478254 0.84 CDK5 (0.40) KCNH2CDK2KMT2AROCK2AURKA
SCHEMBL4492222 0.83 ROCK2 (0.42) KCNH2CDK2KMT2AROCK2AURKA
SCHEMBL3477263 0.82 MKNK1 (0.45) KCNH2CCNA2CDK2MAPK3MAPK1
SCHEMBL3477197 0.82 IKBKB (0.37) KCNH2AKT3KDM4EALDH1A1CCNA2
SCHEMBL4482067 0.81 ROCK2 (0.47) KCNH2CCNA2CDK2MAPK3MAPK1
SCHEMBL3478098 0.81 LMNA (0.41) KCNH2KDM4EALDH1A1CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1615898-B1 2-Aminopyrimidine derivatives and their medical use NOVARTIS AG (CH) 2014-10-29 EP claimed
WO-2010134939-A2 MAMMALIAN GENES INVOLVED IN INFECTION Zirus, Inc. (US) 2010-11-25 WO disclosed